AtriCure (ATRC) Earnings Date, Estimates & Call Transcripts → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free ATRC Stock Alerts $20.89 -1.33 (-5.99%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJul. 23EstimatedActual EPS (May. 1) -$0.25 Missed By -$0.02 Consensus EPS (May. 1) -$0.23 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get AtriCure Earnings AlertsEnter your email address below to receive the latest news and earnings results for ATRC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueATRC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATRC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. AtriCure Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.24)($0.24)($0.24) Q2 20241($0.23)($0.23)($0.23) Q3 20241($0.20)($0.20)($0.20) Q4 20241($0.16)($0.16)($0.16) FY 20244($0.83)($0.83) ($0.83)ATRC Earnings Date and InformationAtriCure last posted its earnings data on May 1st, 2024. The medical device company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.23) by $0.02. The company had revenue of $108.90 million for the quarter, compared to the consensus estimate of $106.86 million. Its quarterly revenue was up 16.5% on a year-over-year basis. AtriCure has generated ($0.80) earnings per share over the last year (($0.80) diluted earnings per share). Earnings for AtriCure are expected to grow in the coming year, from ($0.75) to ($0.52) per share. AtriCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based off prior year's report dates.Read More AtriCure Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/23/2024Estimated)------- 5/1/2024Q1 2024($0.23)($0.25)($0.02)($0.22)$106.86 million$108.90 million 2/15/2024Q4 2023($0.22)($0.21)+$0.01($0.21)$103.68 million$106.50 million 11/1/2023Q3 2023($0.30)($0.20)+$0.10($0.20)$96.65 million$98.29 million 7/25/2023Q2 2023($0.27)($0.12)+$0.15($0.13)$97.55 million$100.92 million 5/2/2023Q1 2023($0.34)($0.23)+$0.11($0.32)$87.53 million$93.49 million 2/21/2023Q4 2022($0.18)($0.09)+$0.09($0.09)$87.90 million$88.00 million Get the Latest News and Ratings for ATRC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AtriCure and its competitors with MarketBeat's FREE daily newsletter. 11/1/2022Q3 2022($0.25)($0.27)($0.02)($0.27)$81.40 million$83.25 million8/2/2022Q2 2022($0.30)($0.32)($0.02)($0.32)$79.55 million$84.53 million 5/3/2022Q1 2022($0.33)($0.33)-($0.33)$71.17 million$74.58 million 2/15/2022Q4 2021($0.26)($0.30)($0.04)($0.30)$72.50 million$73.22 million 11/3/2021Q3 2021($0.28)$2.11+$2.39($2.57)$68.95 million$70.46 million 8/3/2021Q2 2021($0.30)($0.36)($0.06)($0.24)$61.08 million$71.38 million AtriCure Earnings - Frequently Asked Questions When is AtriCure's earnings date? AtriCure has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based off last year's report dates. Learn more on ATRC's earnings history. Did AtriCure beat their earnings estimates last quarter? In the previous quarter, AtriCure (NASDAQ:ATRC) missed the analysts' consensus estimate of ($0.23) by $0.02 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. ATRC's actual earnings. How can I listen to AtriCure's earnings conference call? The conference call for AtriCure's latest earnings report can be listened to online. Listen to Conference Call How can I read AtriCure's conference call transcript? The conference call transcript for AtriCure's latest earnings report can be read online. Read Transcript How can I view AtriCure's earnings report? AtriCure's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AtriCure generate each year? AtriCure (NASDAQ:ATRC) has a recorded annual revenue of $399.24 million. How much profit does AtriCure generate each year? AtriCure (NASDAQ:ATRC) has a recorded net income of -$30.44 million. ATRC has generated -$0.80 earnings per share over the last four quarters. What is AtriCure's EPS forecast for next year? AtriCure's earnings are expected to grow from ($0.75) per share to ($0.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Orthofix Medical Earnings Alphatec Earnings Surmodics Earnings Inovio Pharmaceuticals Earnings Integra LifeSciences Earnings MiMedx Group Earnings NovoCure Earnings Artivion Earnings Paragon 28 Earnings LeMaitre Vascular Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:ATRC) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMysterious Gold Leverage Just AnnouncedStansberry ResearchThe only AI company you should be looking atBehind the MarketsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.